The mitochondrial dysfunction seen in MycKO and DKO MEFs was not unexpected, given that related defects have been described in other normal and cancer cell types following Myc and/or Mlx loss or inhibition [3,10,14,25]. This evidence concerns the gene MLX and cancer.